Position in SCLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$279
-$233 QoQ
Shares Held
42
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Larson Financial Group LLC holds $47,576,049 across 18 Drug Manufacturers - General names. SCLX ranks #18 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
17,014 | $15,648,966 | |
| 2 | ABBV |
AbbVie Inc.
|
35,942 | $7,817,025 | |
| 3 | MRK |
Merck & Co., Inc.
|
59,707 | $7,182,155 | |
| 4 | JNJ |
Johnson & Johnson
|
28,428 | $6,948,940 | |
| 5 | PFE |
Pfizer Inc
|
109,981 | $3,088,266 | |
| 6 | AMGN |
Amgen Inc
|
6,334 | $2,228,617 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
33,017 | $2,002,481 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
12,065 | $1,681,499 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $279 | 42 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $512 | 42 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $826 | 42 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $247 | 42 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||